-
-
-
-
-
-
-
Aviragen Therapeutics (AVIR) Misses Q2 EPS by 3c
-
-
-
-
-
-
-
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Atea Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call on August 7, 2024
-
-
-
-
-
-
-
Aviragen Therapeutics (AVIR) Tops Q3 EPS by 6c
-
-
-
-
-
-
-
Atea Pharmaceuticals Confirms Receipt of Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences
-
-
-
-
-
-
-
Atea Pharmaceuticals to Host Third Quarter 2022 Financial Results Conference Call on November 7, 2022
-
-
-
-
-
-
-
Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on February 28, 2022
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

